Details for New Drug Application (NDA): 204071
✉ Email this page to a colleague
The generic ingredient in SODIUM POLYSTYRENE SULFONATE is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Summary for 204071
Tradename: | SODIUM POLYSTYRENE SULFONATE |
Applicant: | Nuvo Pharms Inc |
Ingredient: | sodium polystyrene sulfonate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 204071
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 204071 | ANDA | Marlex Pharmaceuticals Inc | 10135-146 | 10135-146-14 | 15 g in 1 BOTTLE, PLASTIC (10135-146-14) |
SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 204071 | ANDA | Marlex Pharmaceuticals Inc | 10135-146 | 10135-146-17 | 454 g in 1 JAR (10135-146-17) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL, RECTAL | Strength | 454GM/BOT | ||||
Approval Date: | Nov 28, 2014 | TE: | AA | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL, RECTAL | Strength | 15GM/BOT | ||||
Approval Date: | Nov 28, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription